The role will report to the Operations Strategic Support & Business Analysis Senior Manager within the Global Commercial Portfolio Management Office (GCPMO).
The primary responsibility of the role is to gather and analyze data, providing tactical and strategic recommendations to support operations and the business overall. Specifically, the role involves conducting internal Business Analysis with a focus on Drug Discovery and Development Services and Solutions, customers and partners, and the portfolio across Evotec's Global Operations Business Units.
The role requires close collaboration with colleagues within GCPMO and liaison with internal stakeholders, including Scientific Strategy Leaders, Operations, Finance, IT, and Commercial Managers, to provide data-driven insights and recommendations that support business strategy and decision-making.
Target hire date: 1 October 2026
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.

Evotec is a biotechnology company that is committed to advancing drug discovery and development. Through flexible business models, we collaborate with pharmaceutical companies, biotechs, foundations, and government agencies on a substantial scale. We believe that by working together, we can make a difference in the lives of patients.
Our Pipeline Co-Creation model represents our adaptable, multi-modality, fully integrated end-to-end approach to drive collaborations and services across all phases of drug discovery and development – from discovery of novel targets to achieving Proof of Concept in the clinic and into commercial manufacturing.
We aspire to contribute data-driven disease understanding and early disease relevance in humans to bring the probability of success up. We select the right modality, which is then propelled forward on our platforms by our passionate people striving for the fastest and most effective ways towards patient impact. This is enabled by convergence of human ingenuity with data and AI.
We also offer specific solutions, products, and CRO/CDMO-like services, always in support of the Biopharma R&D innovator. Our more than 4,000 scientists work closely with numerous partners concurrently, delivering fully integrated research and development portfolios or individual projects with the highest quality standards and efficiency, coupled with great science, passion, engagement, and communication.